ATB Antivirals at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

ATB Antivirals at BIO-Europe 2026 in Cologne: 1 session (1 talk).

OrganizationBIO-Europe 2026 Attendance
ATB Antivirals
Turku, Finland
Biotech
Finnish biotech developing antiviral therapies, led by a topical treatment aimed at HPV-infected cells, first for genital warts.
Talk
Mon Nov 9
15:45–16:00
Drug Discovery and Development: ATB Antivirals Ltd
A topical treatment for cells infected with human papillomavirus, first in genital warts, and a nasal spray to prevent respiratory virus infections.

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from ATB Antivirals

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction